Plain-English translation of NCT06664528 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is an observational study that follows cancer patients receiving potentially heart-damaging anti-cancer therapies to learn more about heart health risks and outcomes. Researchers will monitor your heart function through regular clinical visits, blood tests, and heart imaging over 2 years. The goal is to identify which patients are most at risk and find the best ways to catch heart problems early.
Some cancer medications can harm the heart as a side effect, but doctors don't yet have clear ways to predict who will be affected or how to catch these problems earliest. This study aims to fill that gap by identifying warning signs and patterns that could help doctors protect heart health during cancer treatment.
You likely qualify if…
You likely don't qualify if…
You will visit the research clinic regularly over 2 years while you receive cancer treatment. At these visits, doctors will perform clinical exams, draw blood samples, and perform heart ultrasounds to monitor your heart function. The researchers will track your heart health over time to identify any early warning signs and better understand how the cancer medications affect different patients.
AI-generated summary from trial data · Jul 7, 2026 · Not medical advice
Italy